↓ Skip to main content

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Overview of attention for article published in BMC Cancer, July 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
Published in
BMC Cancer, July 2004
DOI 10.1186/1471-2407-4-38
Pubmed ID
Authors

Andreas Teufel, Silke Steinmann, Jürgen Siebler, Christiane Zanke, Herbert Hohl, Bernd Adami, M Schroeder, O Klein, Thomas Höhler, Peter R Galle, Michael Heike, Markus Moehler

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Researcher 7 17%
Student > Bachelor 6 15%
Other 3 7%
Student > Master 3 7%
Other 4 10%
Unknown 11 27%
Readers by discipline Count As %
Medicine and Dentistry 20 49%
Nursing and Health Professions 2 5%
Biochemistry, Genetics and Molecular Biology 2 5%
Business, Management and Accounting 1 2%
Psychology 1 2%
Other 3 7%
Unknown 12 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 November 2021.
All research outputs
#4,825,216
of 23,277,141 outputs
Outputs from BMC Cancer
#1,246
of 8,435 outputs
Outputs of similar age
#9,621
of 54,035 outputs
Outputs of similar age from BMC Cancer
#1
of 13 outputs
Altmetric has tracked 23,277,141 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,435 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 54,035 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.